Trials / Completed
CompletedNCT01556607
A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma
A Double-Blind, Randomized, 3 Period Crossover, Single Ascending Dose Study to Assess the Safety, and Tolerability of Inhaled MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- MicroDose Therapeutx, Inc · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and tolerability of MDT-637, when inhaled by subjects with Intermittent, or Mild-to-Moderate Persistent, Asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MDT-637 | Inhaled doses of MDT-637 over a 24 hour period at 3 visits |
| DRUG | Placebo |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2012-03-16
- Last updated
- 2012-05-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01556607. Inclusion in this directory is not an endorsement.